Abstract:Purpose: The objective of this study was to elucidate the spectrum of brain natriuretic peptide (BNP) expression in hemodialysis patients with euvolemic status and investigate its prognostic significance. Methods: Patients on chronic hemodialysis were enrolled. The normal range of BNP was measured and analyzed in patients with euvolemic status defined by systolic blood pressure and overhydration. Hemodialysis patients were stratified into groups according to BNP expression at baseline and followed up for 57 months, with all-cause mortality and cardiovascular disease-related death being assessed as primary outcomes. Results: BNP significantly correlated with overhydration in all patients (r = 0.255, P = .004). In patients with euvolemic state, the average BNP level was 701 (±645) pg/ml, with a 95% confidence interval (CI) of 500-902 pg/ml. In patients with BNP < 902 pg/ml, systolic blood pressure significantly correlated with overhydration. Elevated BNP expression correlated with an increased risk of cardiovascular mortality (HR = 1.871, per 782 pg/ml increase, P = .008). The patients with continuously high levels of BNP showed significantly increased risk of cardiovascular disease-related death during follow-up (HR = 12.845, P = .005). Conclusion: Predialysis measured BNP levels correlate with volume status, and the common range is from 500 to 902 pg/ml in dialysis patients with euvolemic status. Patients with upregulated BNP expression showed an increased risk of cardiovascular death. Key messages What is already known on this topic The volume management of hemodialysis patients should be judged comprehensively by clinical manifestations and objective examinations. The parameters involved in the evaluation need to be further optimized. What this study adds In hemodialysis patients, BNP serves as an indicator of volume status. Properly hydrated hemodialysis patients typically exhibit BNP levels ranging from 500 to 902 pg/ml, while persistent BNP elevation is associated with increased mortality. How this study might affect research, practice, or policy In clinical practice, BNP can be routinely monitored in hemodialysis patients to provide information for volume adjustment and to identify patients with high mortality risk. The potential advantages of implementing targeted BNP management warrant further investigation through intervention studies.

Higher plasma NT-proBNP levels correlate with syndrome of inappropriate antidiuretic hormone and poor prognosis in neurological patients

Early NT-ProBNP (N-Terminal Probrain Natriuretic Peptide) Elevation Predicts Malignant Edema and Death after Reperfusion Therapy in Acute Ischemic Stroke Patients.

Prognostic Value of B-type Natriuretic Peptide (BNP) and Its Potential Role in Guiding Fluid Therapy in Critically Ill Septic Patients

Elevated N-terminal Pro-Brain-type Natriuretic Peptide at Admission is Associated with Unfavorable Outcomes after Aneurysmal Subarachnoid Hemorrhage

Corelation Between Plasma N-terminal ProBNP(NT-proBNP) and Cardiac Dysfunction

Higher Levels of Admission N-Terminal Pro-brain Natriuretic Peptide Are Associated with Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage

Changes in Brain Natriuretic Peptide Are Correlated with Changes in Global End-Diastolic Volume Index

N-Terminal Pro-Brain Natriuretic Peptide Concentrations After Hypertensive Intracerebral Hemorrhage: Relationship With Hematoma Size, Hyponatremia, and Intracranial Pressure

Association of N-Terminal Pro-brain Natriuretic Peptide With Volume Status and Cardiac Function in Hemodialysis Patients

Variation of brain natriuretic peptide assists with volume management and predicts prognosis of hemodialysis patients

Study on the Relationship between Spontaneous Cerebral Hemorrhage and Serum B-type Brain Natriuretic Peptide

Correlation analysis of N-terminal pro-brain natriuretic peptide in maintenance hemodialysis patients

Association between N-terminal pro-B-type natriuretic peptide and clinical outcomes in bedridden patients with stroke: a cross-sectional study

Plasma Nt-Probnp is Independently Associated with Albuminuria in Type 2 Diabetes

Influencing factors for plasma natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels in senior patients with heart failure

Value of N-terminal pro brain natriuretic peptide in predicting prognosis and severity of coronary artery disease in acute coronary syndrome

Association of Serum N-terminal Pro-Brain Natriuretic Peptide Levels with Survival and Renal Outcomes among Elderly Patients with Acute Kidney Injury in Chronic Heart Failure

[A study of plasma atrial natriuretic peptide, antidiuretic hormone and aldosterone levels in a series of patients with intracranial disease and hyponatremia].

Plasma Concentration of NT-proBNP in Patients with Acute Coronary Syndrome Correlated with the Severity of the Diseases?

The Relationship between Cardiac Hemodynamics and the Level of Plasma NT-proBNP in Patients with Acute Coronary Syndrome

Predictive Value of N-terminal Pro-B-type Natriuretie Peptide on Prognosis of Critically Ill Patients in Surgical Intensive Care Unit and Its Possible Influential Factors